OliX Pharmaceuticals
is a clinical stage pharmaceutical company developing therapeutics
against a variety of disorders based on its proprietary RNAi technology.
We do not allow the unauthorized collection of e-mail addresses listed on our website.Persons engaging in unauthorized collection with e-mail address collection programs or other technical devices will be subject to criminal prosecution in accordance with the Act on Information & Communications Network Utilization and Information Protection.
RNAi platform development
Lead compound discovery
Pharmacological research on OliX RNAi compounds for respiratory and neurological diseases
Pharmacological research on OliX RNAi compounds for ocular diseases
Testing efficacy of oligonucleotide therapeutics using animal models
Develop analytical methods for therapeutic candidates to determine purity and stability in support of nonclinical and clinical studies
Develop bioanalytical methods to quantitate therapeutic candidates in biological matrices for pharmacokinetic and toxicokinetic (PK/TK) studies
Manage manufacturing, analytics and quality of therapeutic candidates
Conduct safety evaluation and toxicokinetic assessment of therapeutic candidates through nonclinical studies
Establish clinical development plans for therapeutic candidates and conduct clinical studies
Business Management
Purchasing
General Affairs
Facility Management
Contingency Planning
Budget/Performance Management
Mid to Long-term Business Goals/Strategy Planning
Make official announcements about business contents, financial condition, business performance etc.
Stabilize Internal Accounting Control System
IT Infrastructure Management
IT Helpdesk
HR Policy/System Establishment, Organization/Job Design
Recruitment/HR Management
Performance Management, Employee Welfare
HR Development
Prevent, respond, handle legal disputes
Provide risk management and compliance support
Develop IP strategies for core technologies
Verify pharmaceutical R&D processes and results
Ensure product to meet the established quality standards
Develop/Maintain Client Relationships
Execute Licensing Agreements
New Business/Strategy Planning
Provide investment information in a timely manner to increase company value
Promote management activities and establish internal/external communication strategies
Create positive corporate culture through various in-house activities and employee education
is a clinical stage pharmaceutical company developing therapeutics
against a variety of disorders based on its proprietary RNAi technology.
Since the discovery of RNA interference technology, RNAi has been widely recognized as the third drug development platform, after small molecule and protein (antibody) drugs. It is now changing the paradigm of therapeutic development.
OliX’s cp-asiRNA technology, our proprietary RNAi triggering structure, offers a simple and elegant solution for the intracellular delivery of asiRNA with minimized adverse effects. Currently, OliX is developing locally administrable RNAi therapeutics for dermal, ophthalmic, and pulmonary diseases at a lower cost and shorter time. We have also secured GalNAc-asiRNA to target various liver diseases.
Beginning with a license and collaboration agreement on our ophthalmic program OLX301A (2019), we recently signed an expanded agreement with Théa Open Innovation on OLX301A and OLX301D (2020), being recognized again as a global RNAi therapeutics company.
For the general welfare of human beings, OliX has been and will constantly endeavor to become a leader in the worldwide biotechnology industry.
Thank you for your support and interest in OliX Pharmaceuticals.